MedTrace Logo

AngioVac Aspiration Therapy Registry

NCT07769320 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-08-17

No results posted yet for this study

Summary

As a structured, multinational retrospective registry the AVATAR Registry addresses the following scientific aspects through systematic data collection, centralized quality control, and robust statistical analysis in patients that were treated with the AngioVac Aspiration System:

1. Quantify Real-World Safety: Composite adverse event rates across diverse populations and indications
2. Assess Effectiveness: Technical and clinical success rates stratified by indication
3. Identify Predictors: Clinical, procedural, and anatomical factors predicting success versus complications
4. Generate Publishable Cohorts: Sufficient statistical power (approx. 1000 patients across 8 indication cohorts) for:

* Indication-specific outcomes
* Multivariable prediction models
* Time-to-event analyses (30-day and 12-month mortality)
5. Establish Best Practices: Evidence-based recommendations for patient selection, procedural technique, and follow-up

Conditions

  • Intracardiac Thrombus
  • Intracardiac Mass
  • Intravascular Thrombosis
  • Vegetation; Heart
  • Vegetation; Endocarditis
  • Vegetation on Catheter
  • Thrombus of Right Atrium
  • Thrombus of Right Ventricle
  • Thrombus Inferior Vena Cava
  • Thrombus of Pacemaker Electrode
  • Endocarditis Infective
  • Endocarditis, Bacterial
  • Thrombus of Pulmonary Artery
  • Thrombus on Catheter

Interventions

OTHER

Retrospective analysis of assigned treatment

Participants are not assigned an intervention as part of the study

Sponsors & Collaborators

  • Angiodynamics, Inc.

    collaborator INDUSTRY

  • Deutsches Herzzentrum der Charité

    collaborator UNKNOWN

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Christoph Starck, Prof. Dr. med. · Charité University Berlin, Deutsches Herzzentrum der Charité

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07769320 on ClinicalTrials.gov